Breaking News Instant updates and real-time market news.

USO

United States Oil Fund

$30.82 /

-0.43 (-1.38%)

, BP

BP

$19.93 /

-1.18 (-5.59%)

12:38
11/30/20
11/30
12:38
11/30/20
12:38

OPEC sees 'immense challenges' from COVID-19 persisting into 2021, CNBC says

OPEC warned that the "immense challenges" caused by the coronavirus crisis will likely continue into 2021, as the group of oil producers continues talks over an extension to its production reduction agreement, CNBC's Dan Murphy reports. "The shock to the oil industry is massive and its severe impacts will likely reverberate in the years to come," Abdelmadjid Attar, OPEC president and Algeria's energy minister, told the group. "The pandemic continues to rage with cases soaring in many regions around the world. It continues to affect adversely the global economy and, consequently, the world energy markets, in an unprecedented manner." Publicly traded companies in the space include BP (BP), Chevron (CVX), ConocoPhillips (COP), Exxon Mobil (XOM), Royal Dutch Shell (RDS.A) and Total (TOT). Reference Link

USO

United States Oil Fund

$30.82 /

-0.43 (-1.38%)

BP

BP

$19.93 /

-1.18 (-5.59%)

COP

ConocoPhillips

$40.97 /

-1.85 (-4.32%)

TOT

Total

$42.87 /

-2.34 (-5.18%)

XOM

Exxon Mobil

$38.59 /

-1.62 (-4.03%)

CVX

Chevron

$88.72 /

-2.59 (-2.84%)

RDS.A

Royal Dutch Shell

$34.47 /

-1.77 (-4.88%)

  • 03

    Dec

  • 09

    Mar

USO United States Oil Fund
$30.82 /

-0.43 (-1.38%)

BP BP
$19.93 /

-1.18 (-5.59%)

11/30/20 HSBC
BP downgraded to Hold from Buy at HSBC
11/30/20 HSBC
BP downgraded to Hold from Buy at HSBC
11/17/20 RBC Capital
BP upgraded to Sector Perform from Underperform at RBC Capital
11/02/20 Morgan Stanley
BP upgraded to Equal Weight from Underweight at Morgan Stanley
COP ConocoPhillips
$40.97 /

-1.85 (-4.32%)

11/20/20 Stifel
Concho Resources downgraded to Hold from Buy at Stifel
11/17/20 Morgan Stanley
Concho Resources downgraded to Equal Weight at Morgan Stanley
11/16/20 Truist
Exxon Mobil price target raised to $39 from $36 at Truist
11/02/20 BofA
ConocoPhillips upgraded to Buy from Neutral at BofA
TOT Total
$42.87 /

-2.34 (-5.18%)

11/19/20 Scotiabank
Total price target raised to $46 from $44 at Scotiabank
10/01/20 UBS
Total price target lowered to EUR 41 from EUR 44 at UBS
09/24/20 Scotiabank
Scotiabank adds EU super majors to coverage, shakes up oil ratings
09/23/20 Scotiabank
Total initiated with a Sector Perform at Scotiabank
XOM Exxon Mobil
$38.59 /

-1.62 (-4.03%)

11/02/20 Credit Suisse
Exxon Mobil price target lowered to $37 from $47 at Credit Suisse
10/13/20
Fly Intel: Top five analyst upgrades
10/13/20 Goldman Sachs
Exxon Mobil upgraded to Neutral from Sell at Goldman Sachs
CVX Chevron
$88.72 /

-2.59 (-2.84%)

11/17/20
Fly Intel: Top five analyst upgrades
11/17/20 RBC Capital
Chevron upgraded to Sector Perform from Underperform at RBC Capital
10/21/20 Morgan Stanley
Cimarex, Diamondback could benefit from greater scale, says Morgan Stanley
RDS.A Royal Dutch Shell
$34.47 /

-1.77 (-4.88%)

11/20/20 Morgan Stanley
Royal Dutch Shell price target raised to 1,308 GBp at Morgan Stanley
11/19/20 Scotiabank
Royal Dutch Shell price target raised to $45 from $38 at Scotiabank
11/11/20 Berenberg
Royal Dutch Shell upgraded to Buy from Hold at Berenberg
11/09/20 HSBC
Royal Dutch Shell upgraded to Buy at HSBC on improved FCF outlook

TODAY'S FREE FLY STORIES

Earnings
Business First Bancshares reports Q4 EPS 68c, consensus 50c » 16:04
01/25/21
01/25
16:04
01/25/21
16:04
BFST

Business First Bancshares

$21.01 /

-0.235 (-1.11%)

For the quarter ended…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BFST Business First Bancshares
$21.01 /

-0.235 (-1.11%)

05/01/20 DA Davidson
Business First Bancshares downgraded to Neutral from Buy at DA Davidson
05/01/20 DA Davidson
Business First Bancshares downgraded to Neutral from Buy at DA Davidson
04/29/20 Raymond James
Business First Bancshares double downgraded to Market Perform at Raymond James
04/29/20 Raymond James
Business First Bancshares downgraded to Market Perform at Raymond James
BFST Business First Bancshares
$21.01 /

-0.235 (-1.11%)

Earnings
Axonics sees Q4 revenue $34.7M-$34.9M, consensus $35.48M » 16:04
01/25/21
01/25
16:04
01/25/21
16:04
AXNX

Axonics

$55.05 /

-1.51 (-2.67%)

The company states:…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AXNX Axonics
$55.05 /

-1.51 (-2.67%)

AXNX Axonics
$55.05 /

-1.51 (-2.67%)

01/07/21 Morgan Stanley
Axonics price target raised to $58 from $53 at Morgan Stanley
12/01/20 BofA
ShockWave Medical downgraded to Neutral from Buy at BofA
11/24/20 Piper Sandler
Piper says accelerating SNM market an underappreciated positive for Axonics
11/05/20 Truist
Axonics price target raised to $58 from $50 at Truist
AXNX Axonics
$55.05 /

-1.51 (-2.67%)

  • 08
    May
AXNX Axonics
$55.05 /

-1.51 (-2.67%)

Recommendations
Cantor says Amarin opportunity for Vascepa outside U.S. still 'underappreciated' » 16:03
01/25/21
01/25
16:03
01/25/21
16:03
AMRN

Amarin

$7.59 /

+1.025 (+15.63%)

Cantor Fitzgerald analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AMRN Amarin
$7.59 /

+1.025 (+15.63%)

AMRN Amarin
$7.59 /

+1.025 (+15.63%)

08:46 Today Piper Sandler
Piper Sandler reiterates 'conviction call' on Amarin into European decision
01/22/21 Cowen
Amarin remains undervalued under almost any scenario, says Cowen
01/08/21 Piper Sandler
Piper sees 're-birth' for Amarin shares in 2021, keeps $19 price target
12/28/20 Cantor Fitzgerald
Vascepa showing positive year-over-year trends, says Cantor Fitzgerald
AMRN Amarin
$7.59 /

+1.025 (+15.63%)

AMRN Amarin
$7.59 /

+1.025 (+15.63%)

AMRN Amarin
$7.59 /

+1.025 (+15.63%)

AMRN Amarin
$7.59 /

+1.025 (+15.63%)

Hot Stocks
Koru Medical names Jim Beck interim CEO » 16:03
01/25/21
01/25
16:03
01/25/21
16:03
KRMD

Koru Medical

$5.11 /

-0.08 (-1.54%)

Koru Medical announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
KRMD Koru Medical
$5.11 /

-0.08 (-1.54%)

KRMD Koru Medical
$5.11 /

-0.08 (-1.54%)

11/04/20 Piper Sandler
Koru Medical earnings selloff a buying opportunity, says Piper Sandler
08/10/20 H.C. Wainwright
KORU Medical Systems initiated with a Buy at H.C. Wainwright
08/05/20 Piper Sandler
KORU Medical Systems price target raised to $14 from $12 at Piper Sandler
07/16/20 Canaccord
KORU Medical Systems initiated with a Buy at Canaccord
KRMD Koru Medical
$5.11 /

-0.08 (-1.54%)

  • 19
    Jun
KRMD Koru Medical
$5.11 /

-0.08 (-1.54%)

KRMD Koru Medical
$5.11 /

-0.08 (-1.54%)

Earnings
J & J Snack Foods reports Q1 EPS 9c, two estimates 20c » 16:03
01/25/21
01/25
16:03
01/25/21
16:03
JJSF

J & J Snack Foods

$156.72 /

+3.83 (+2.51%)

Reports Q1 revenue $241M,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
JJSF J & J Snack Foods
$156.72 /

+3.83 (+2.51%)

JJSF J & J Snack Foods
$156.72 /

+3.83 (+2.51%)

05/12/20 CL King
J & J Snack Foods upgraded to Buy from Neutral at CL King
JJSF J & J Snack Foods
$156.72 /

+3.83 (+2.51%)

Recommendations
South Carolina award 'a lost opportunity' for Benefitfocus, says Raymond James » 16:02
01/25/21
01/25
16:02
01/25/21
16:02
BNFT

Benefitfocus

$13.84 /

-0.19 (-1.35%)

Raymond James analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BNFT Benefitfocus
$13.84 /

-0.19 (-1.35%)

BNFT Benefitfocus
$13.84 /

-0.19 (-1.35%)

01/21/21 Raymond James
Benefitfocus downgraded at Raymond James on 'aggressive' consensus estimates
01/21/21 Raymond James
Benefitfocus downgraded to Market Perform from Outperform at Raymond James
11/06/20 Cantor Fitzgerald
Benefitfocus downgraded to Neutral from Overweight at Cantor Fitzgerald
11/06/20 Cantor Fitzgerald
Benefitfocus downgraded to Neutral from Overweight at Cantor Fitzgerald
BNFT Benefitfocus
$13.84 /

-0.19 (-1.35%)

Syndicate
Seelos Therapeutics announces common stock offering, no amount given » 16:02
01/25/21
01/25
16:02
01/25/21
16:02
SEEL

Seelos Therapeutics

$2.59 /

+0.005 (+0.19%)

Seelos Therapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SEEL Seelos Therapeutics
$2.59 /

+0.005 (+0.19%)

SEEL Seelos Therapeutics
$2.59 /

+0.005 (+0.19%)

09/09/20 Roth Capital
Seelos Therapeutics shares 'substantially undervalued,' says Roth Capital
06/23/20 Roth Capital
Seelos Therapeutics price target raised to $12 from $8 Roth Capital
  • 12
    Mar
  • 11
    Feb
Earnings
Koru Medical reports preliminary FY20 revenue $24M, consensus $25.9M » 16:02
01/25/21
01/25
16:02
01/25/21
16:02
KRMD

Koru Medical

$5.11 /

-0.08 (-1.54%)

Preliminary cash, cash…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
KRMD Koru Medical
$5.11 /

-0.08 (-1.54%)

KRMD Koru Medical
$5.11 /

-0.08 (-1.54%)

11/04/20 Piper Sandler
Koru Medical earnings selloff a buying opportunity, says Piper Sandler
08/10/20 H.C. Wainwright
KORU Medical Systems initiated with a Buy at H.C. Wainwright
08/05/20 Piper Sandler
KORU Medical Systems price target raised to $14 from $12 at Piper Sandler
07/16/20 Canaccord
KORU Medical Systems initiated with a Buy at Canaccord
KRMD Koru Medical
$5.11 /

-0.08 (-1.54%)

  • 19
    Jun
KRMD Koru Medical
$5.11 /

-0.08 (-1.54%)

KRMD Koru Medical
$5.11 /

-0.08 (-1.54%)

Hot Stocks
Nanobiotix to partner with Sanofi on gene therapy pipeline » 16:02
01/25/21
01/25
16:02
01/25/21
16:02
NANO

Nanobiotix

$0.00 /

+ (+0.00%)

, SNY

Sanofi

$49.51 /

-0.2 (-0.40%)

The company states:…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SNY Sanofi
$49.51 /

-0.2 (-0.40%)

NANO Nanobiotix
$0.00 /

+ (+0.00%)

SNY Sanofi
$49.51 /

-0.2 (-0.40%)

01/19/21 UBS
Sanofi price target lowered to EUR 99 from EUR 100 at UBS
01/15/21 Deutsche Bank
Sanofi initiated with a Sell at Deutsche Bank
01/08/21 Morgan Stanley
Sanofi price target raised to EUR 105 from EUR 101 at Morgan Stanley
01/08/21 Morgan Stanley
Roche downgraded to Equal Weight from Overweight at Morgan Stanley
SNY Sanofi
$49.51 /

-0.2 (-0.40%)

SNY Sanofi
$49.51 /

-0.2 (-0.40%)

SNY Sanofi
$49.51 /

-0.2 (-0.40%)

Syndicate
Lipocine announces common stock offering, no amount given » 16:01
01/25/21
01/25
16:01
01/25/21
16:01
LPCN

Lipocine

$2.20 /

-0.04 (-1.79%)

Lipocine announced that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
LPCN Lipocine
$2.20 /

-0.04 (-1.79%)

LPCN Lipocine
$2.20 /

-0.04 (-1.79%)

12/10/20 Ladenburg
Lipocine upgraded to Buy after tentative Tlando approval at Ladenburg
12/10/20 Ladenburg
Lipocine upgraded to Buy from Neutral at Ladenburg
05/27/20 H.C. Wainwright
Lipocine price target raised to $3 from $2 at H.C. Wainwright
LPCN Lipocine
$2.20 /

-0.04 (-1.79%)

LPCN Lipocine
$2.20 /

-0.04 (-1.79%)

LPCN Lipocine
$2.20 /

-0.04 (-1.79%)

Downgrade
UBS downgrades AU Optronics to Neutral with LCD cycle likely cooling off » 15:56
01/25/21
01/25
15:56
01/25/21
15:56
AUO

AU Optronics

$0.00 /

+ (+0.00%)

UBS analyst Nicolas…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AUO AU Optronics
$0.00 /

+ (+0.00%)

AUO AU Optronics
$0.00 /

+ (+0.00%)

15:48 Today UBS
AU Optronics downgraded to Neutral from Buy at UBS
07/30/20 JPMorgan
AU Optronics upgraded to Overweight from Underweight at JPMorgan
06/17/20
Fly Intel: Top five analyst upgrades
06/17/20 Credit Suisse
AU Optronics upgraded to Outperform from Neutral at Credit Suisse
Upgrade
Remy Cointreau upgraded to Buy from Hold at Deutsche Bank » 15:48
01/25/21
01/25
15:48
01/25/21
15:48
REMYY

Remy Cointreau

$0.00 /

+ (+0.00%)

Deutsche Bank analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
REMYY Remy Cointreau
$0.00 /

+ (+0.00%)

14:57 Today Barclays
Remy Cointreau price target raised to EUR 169 from EUR 163 at Barclays
14:39 Today Morgan Stanley
Remy Cointreau price target raised to EUR 129 from EUR 125 at Morgan Stanley
13:05 Today Credit Suisse
Remy Cointreau price target raised to EUR 132 from EUR 130 at Credit Suisse
01/15/21 Berenberg
Remy Cointreau price target raised to EUR 131.70 from EUR 130 at Berenberg
Downgrade
AU Optronics downgraded to Neutral from Buy at UBS » 15:48
01/25/21
01/25
15:48
01/25/21
15:48
AUO

AU Optronics

$0.00 /

+ (+0.00%)

UBS downgraded AU…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AUO AU Optronics
$0.00 /

+ (+0.00%)

AUO AU Optronics
$0.00 /

+ (+0.00%)

07/30/20 JPMorgan
AU Optronics upgraded to Overweight from Underweight at JPMorgan
06/17/20
Fly Intel: Top five analyst upgrades
06/17/20 Credit Suisse
AU Optronics upgraded to Outperform from Neutral at Credit Suisse
02/06/20 CLSA
AU Optronics upgraded to Outperform from Underperform at CLSA
Upgrade
Citi upgrades Passage Bio to Buy after pullback and ahead of data » 15:47
01/25/21
01/25
15:47
01/25/21
15:47
PASG

Passage Bio

$20.17 /

+0.16 (+0.80%)

As previously reported,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PASG Passage Bio
$20.17 /

+0.16 (+0.80%)

PASG Passage Bio
$20.17 /

+0.16 (+0.80%)

15:38 Today Citi
Passage Bio upgraded to Buy from Neutral at Citi
06:37 Today Wedbush
Passage Bio initiated with an Outperform at Wedbush
01/04/21 Chardan
Lifting hold on PGBM01 a 'broad positive' for Passage Bio pipeline, says Chardan
01/04/21 JPMorgan
Passage Bio upgraded to Overweight at JPMorgan after clinical hold lifted
PASG Passage Bio
$20.17 /

+0.16 (+0.80%)

  • 22
    Jan
  • 28
    Feb
PASG Passage Bio
$20.17 /

+0.16 (+0.80%)

PASG Passage Bio
$20.17 /

+0.16 (+0.80%)

Options
Rite Aid call volume above normal and directionally bullish » 15:45
01/25/21
01/25
15:45
01/25/21
15:45
RAD

Rite Aid

$21.64 /

+1.87 (+9.46%)

Bullish option flow…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RAD Rite Aid
$21.64 /

+1.87 (+9.46%)

RAD Rite Aid
$21.64 /

+1.87 (+9.46%)

12/18/20 Deutsche Bank
Rite Aid price target raised to $17 from $9 at Deutsche Bank
11/17/20 Oppenheimer
Amazon's Pharmacy push should continue to disrupt supply chain, says Oppenheimer
11/17/20 Goldman Sachs
Goldman says Amazon news likely to pressure entire pharmacy supply chain
09/25/20 Deutsche Bank
Rite Aid price target lowered to $9 from $18 at Deutsche Bank
RAD Rite Aid
$21.64 /

+1.87 (+9.46%)

RAD Rite Aid
$21.64 /

+1.87 (+9.46%)

RAD Rite Aid
$21.64 /

+1.87 (+9.46%)

RAD Rite Aid
$21.64 /

+1.87 (+9.46%)

Upgrade
Passage Bio upgraded to Buy from Neutral at Citi » 15:38
01/25/21
01/25
15:38
01/25/21
15:38
PASG

Passage Bio

$20.30 /

+0.29 (+1.45%)

Citi analyst Neena…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PASG Passage Bio
$20.30 /

+0.29 (+1.45%)

PASG Passage Bio
$20.30 /

+0.29 (+1.45%)

06:37 Today Wedbush
Passage Bio initiated with an Outperform at Wedbush
01/04/21 Chardan
Lifting hold on PGBM01 a 'broad positive' for Passage Bio pipeline, says Chardan
01/04/21 JPMorgan
Passage Bio upgraded to Overweight at JPMorgan after clinical hold lifted
01/04/21 JPMorgan
Passage Bio upgraded to Overweight from Neutral at JPMorgan
PASG Passage Bio
$20.30 /

+0.29 (+1.45%)

  • 22
    Jan
  • 28
    Feb
PASG Passage Bio
$20.30 /

+0.29 (+1.45%)

PASG Passage Bio
$20.30 /

+0.29 (+1.45%)

Hot Stocks
Google workers across the world form global union alliance » 15:36
01/25/21
01/25
15:36
01/25/21
15:36
GOOG

Alphabet

$1,885.31 /

-16.56 (-0.87%)

, GOOGL

Alphabet Class A

$1,880.16 /

-13.43 (-0.71%)

UNI Global Union said…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GOOG Alphabet
$1,885.31 /

-16.56 (-0.87%)

GOOGL Alphabet Class A
$1,880.16 /

-13.43 (-0.71%)

GOOG Alphabet
$1,885.31 /

-16.56 (-0.87%)

08:44 Today Morgan Stanley
Morgan Stanley says market closer to recognizing Alphabet sum-of-the-parts value
08:15 Today Canaccord
Alphabet price target raised to $2250 from $2050 at Canaccord
07:09 Today Mizuho
Alphabet price target raised to $2,100 from $1,810 at Mizuho
01/21/21
Fly Intel: Top five analyst initiations
GOOGL Alphabet Class A
$1,880.16 /

-13.43 (-0.71%)

08:44 Today Morgan Stanley
Morgan Stanley says market closer to recognizing Alphabet sum-of-the-parts value
07:09 Today Mizuho
Alphabet price target raised to $2,100 from $1,810 at Mizuho
01/21/21
Fly Intel: Top five analyst initiations
01/20/21 Piper Sandler
Alphabet assumed with an Overweight at Piper Sandler
GOOG Alphabet
$1,885.31 /

-16.56 (-0.87%)

GOOGL Alphabet Class A
$1,880.16 /

-13.43 (-0.71%)

GOOG Alphabet
$1,885.31 /

-16.56 (-0.87%)

GOOGL Alphabet Class A
$1,880.16 /

-13.43 (-0.71%)

GOOG Alphabet
$1,885.31 /

-16.56 (-0.87%)

GOOGL Alphabet Class A
$1,880.16 /

-13.43 (-0.71%)

GOOG Alphabet
$1,885.31 /

-16.56 (-0.87%)

GOOGL Alphabet Class A
$1,880.16 /

-13.43 (-0.71%)

Options
Boot Barn options imply 11.4% move in share price post-earnings » 15:34
01/25/21
01/25
15:34
01/25/21
15:34
BOOT

Boot Barn

$58.90 /

+0.53 (+0.91%)

Pre-earnings options…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BOOT Boot Barn
$58.90 /

+0.53 (+0.91%)

BOOT Boot Barn
$58.90 /

+0.53 (+0.91%)

01/22/21 Williams Capital
Boot Barn initiated with a Buy at Williams Trading
01/14/21 JPMorgan
Boot Barn price target raised to $63 from $60 at JPMorgan
01/12/21 Cowen
Boot Barn price target raised to $65 from $47 at Cowen
01/11/21 Craig-Hallum
Boot Barn price target raised to $48 from $34 at Craig-Hallum
BOOT Boot Barn
$58.90 /

+0.53 (+0.91%)

BOOT Boot Barn
$58.90 /

+0.53 (+0.91%)

On The Fly
Fly Insider: OncoCyte, Air Transport among week's notable insider trades » 15:20
01/25/21
01/25
15:20
01/25/21
15:20
OCX

OncoCyte

$5.92 /

+1.21 (+25.69%)

, ALDX

Aldeyra

$11.99 /

-0.27 (-2.20%)

, BRN

Barnwell Industries

$2.12 /

+0.01 (+0.47%)

, HCDI

Harbor Custom Development

$3.33 /

-0.01 (-0.30%)

, AMKR

Amkor Technology

$17.73 /

-0.73 (-3.95%)

, AMK

AssetMark Financial

$24.59 /

-0.065 (-0.26%)

, AMSC

AMSC

$27.81 /

-1.56 (-5.31%)

, ATSG

Air Transport Services

$26.54 /

-0.92 (-3.35%)

Welcome to "Fly Insider,"…

ShowHide Related Items >><<
OCX OncoCyte
$5.92 /

+1.21 (+25.69%)

ALDX Aldeyra
$11.99 /

-0.27 (-2.20%)

HCDI Harbor Custom Development
$3.33 /

-0.01 (-0.30%)

AMKR Amkor Technology
$17.73 /

-0.73 (-3.95%)

AMK AssetMark Financial
$24.59 /

-0.065 (-0.26%)

AMSC AMSC
$27.81 /

-1.56 (-5.31%)

ATSG Air Transport Services
$26.54 /

-0.92 (-3.35%)

OCX OncoCyte
$5.92 /

+1.21 (+25.69%)

01/05/21 Benchmark
GM, Roku, Marcus among Benchmark's Best Ideas for first half of 2021
12/17/20 BTIG
BTIG positive on select healthcare diagnostic/tools names as '2021 Top Picks'
12/16/20 Piper Sandler
OncoCyte upgraded to Overweight from Neutral at Piper Sandler
11/30/20 BTIG
OncoCyte initiated with a Buy at BTIG
ALDX Aldeyra
$11.99 /

-0.27 (-2.20%)

01/08/21 Jefferies
Aldeyra could double if topline of TRANQUILITY study positive, says Jefferies
01/08/21 Citi
Aldeyra shares have 'plenty of upside' despite 26% rally, says Citi
01/07/21 Alliance Global Partners
Aldeyra in an 'enviable position' after Phase 3 Tranquility data, says AGP
12/16/20 Berenberg
Berenberg starts Aldeyra with Buy, sees near-term catalysts
BRN Barnwell Industries
$2.12 /

+0.01 (+0.47%)

HCDI Harbor Custom Development
$3.33 /

-0.01 (-0.30%)

AMKR Amkor Technology
$17.73 /

-0.73 (-3.95%)

06:38 Today Citi
Citi moves Marvell up to pick in semiconductor equipment
06:28 Today Citi
Amkor Technology price target raised to $13 from $11.40 at Citi
11/19/20 Citi
Citi moves Lam Research, Marvell to top picks in Semi Equipment
10/27/20 Deutsche Bank
Amkor Technology price target raised to $16 from $14 at Deutsche Bank
AMK AssetMark Financial
$24.59 /

-0.065 (-0.26%)

12/18/20 Truist
AssetMark Financial initiated with a Hold at Truist
09/23/20 Jefferies
AssetMark Financial initiated with a Hold at Jefferies
08/05/20 JPMorgan
AssetMark Financial downgraded on growth slowdown at JPMorgan
08/05/20 JPMorgan
AssetMark Financial downgraded to Neutral from Overweight at JPMorgan
AMSC AMSC
$27.81 /

-1.56 (-5.31%)

11/06/20 Canaccord
AMSC downgraded to Hold at Canaccord
11/06/20 Canaccord
AMSC downgraded to Hold from Buy at Canaccord
11/05/20 Roth Capital
AMSC price target raised to $20 from $18 at Roth Capital
10/07/20 Craig-Hallum
AMSC price target raised to $21 from $15 at Craig-Hallum
ATSG Air Transport Services
$26.54 /

-0.92 (-3.35%)

10/12/20 Loop Capital
Air Transport Services upgraded to Buy from Hold at Loop Capital
06/04/20 Stephens
Amazon leases more proof of strong demand for Air Transport, says Stephens
05/01/20 SunTrust
Air Transport Services initiated with a Buy at SunTrust
05/01/20 SunTrust
Air Transport Services initiated with a Buy at SunTrust
OCX OncoCyte
$5.92 /

+1.21 (+25.69%)

ALDX Aldeyra
$11.99 /

-0.27 (-2.20%)

HCDI Harbor Custom Development
$3.33 /

-0.01 (-0.30%)

AMKR Amkor Technology
$17.73 /

-0.73 (-3.95%)

AMK AssetMark Financial
$24.59 /

-0.065 (-0.26%)

AMSC AMSC
$27.81 /

-1.56 (-5.31%)

ATSG Air Transport Services
$26.54 /

-0.92 (-3.35%)

  • 14
    Jan
  • 13
    Jan
  • 22
    Oct
  • 07
    Aug
OCX OncoCyte
$5.92 /

+1.21 (+25.69%)

ALDX Aldeyra
$11.99 /

-0.27 (-2.20%)

HCDI Harbor Custom Development
$3.33 /

-0.01 (-0.30%)

AMKR Amkor Technology
$17.73 /

-0.73 (-3.95%)

AMSC AMSC
$27.81 /

-1.56 (-5.31%)

AMKR Amkor Technology
$17.73 /

-0.73 (-3.95%)

Periodicals
Italy issues warning letter to Pfizer due to COVID vaccine delays, Reuters says » 15:19
01/25/21
01/25
15:19
01/25/21
15:19
PFE

Pfizer

$37.10 /

+0.555 (+1.52%)

The Italian government…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PFE Pfizer
$37.10 /

+0.555 (+1.52%)

PFE Pfizer
$37.10 /

+0.555 (+1.52%)

01/14/21 Morgan Stanley
80%+ efficacy from J&J vaccine would be 'compelling,' says Morgan Stanley
01/14/21 Oppenheimer
Essa Pharma price target raised to $20 from $9 at Oppenheimer
01/05/21 Argus
Viatris initiated with a Hold at Argus
12/31/20 Ladenburg
UK study supports potential of Arcturus COVID vaccine candidate, says Ladenburg
PFE Pfizer
$37.10 /

+0.555 (+1.52%)

PFE Pfizer
$37.10 /

+0.555 (+1.52%)

PFE Pfizer
$37.10 /

+0.555 (+1.52%)

PFE Pfizer
$37.10 /

+0.555 (+1.52%)

Options
Xilinx options imply 10.8% move in share price post-earnings » 15:19
01/25/21
01/25
15:19
01/25/21
15:19
XLNX

Xilinx

$144.50 /

+1.48 (+1.03%)

Pre-earnings options…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
XLNX Xilinx
$144.50 /

+1.48 (+1.03%)

XLNX Xilinx
$144.50 /

+1.48 (+1.03%)

12/30/20 Rosenblatt
Activist a 'new stage in the Intel journey of decline,' says Rosenblatt
12/28/20 Mizuho
Xilinx price target raised to $150 from $112 at Mizuho
12/17/20 Deutsche Bank
Xilinx price target raised to $155 from $143 at Deutsche Bank
11/23/20 RBC Capital
AMD price target raised to $100 from $92 at RBC Capital
XLNX Xilinx
$144.50 /

+1.48 (+1.03%)

XLNX Xilinx
$144.50 /

+1.48 (+1.03%)

XLNX Xilinx
$144.50 /

+1.48 (+1.03%)

XLNX Xilinx
$144.50 /

+1.48 (+1.03%)

Technical Analysis
NASDAQ market internals summary » 15:17
01/25/21
01/25
15:17
01/25/21
15:17
$NSD

NASDAQ Market Internals

$0.00 /

+ (+0.00%)

Volume is above average…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
$NSD NASDAQ Market Internals
$0.00 /

+ (+0.00%)

Technical Analysis
NYSE market internals summary » 15:16
01/25/21
01/25
15:16
01/25/21
15:16
$NYE

NYSE Market Internals

$0.00 /

+ (+0.00%)

Volume is above average…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
$NYE NYSE Market Internals
$0.00 /

+ (+0.00%)

Options
Steel Dynamics options imply 4.8% move in share price post-earnings » 15:04
01/25/21
01/25
15:04
01/25/21
15:04
STLD

Steel Dynamics

$38.27 /

-0.45 (-1.16%)

Pre-earnings options…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
STLD Steel Dynamics
$38.27 /

-0.45 (-1.16%)

STLD Steel Dynamics
$38.27 /

-0.45 (-1.16%)

12/09/20 Morgan Stanley
Steel Dynamics initiated with an Overweight at Morgan Stanley
10/21/20 BMO Capital
Steel Dynamics price target raised to $35 from $32 at BMO Capital
09/18/20 BMO Capital
Steel Dynamics price target raised to $32 from $29 at BMO Capital
07/29/20 Deutsche Bank
Steel Dynamics price target raised to $31 from $27 at Deutsche Bank
STLD Steel Dynamics
$38.27 /

-0.45 (-1.16%)

STLD Steel Dynamics
$38.27 /

-0.45 (-1.16%)

STLD Steel Dynamics
$38.27 /

-0.45 (-1.16%)

Hot Stocks
Entercom announces launch of 'BetQL Audio Network' » 14:58
01/25/21
01/25
14:58
01/25/21
14:58
ETM

Entercom

$3.94 /

-0.15 (-3.67%)

Entercom announced the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ETM Entercom
$3.94 /

-0.15 (-3.67%)

ETM Entercom
$3.94 /

-0.15 (-3.67%)

01/19/21 Wells Fargo
Entercom upgraded to Overweight at Wells Fargo on compelling risk/reward
01/19/21 Wells Fargo
Entercom upgraded to Overweight from Equal Weight at Wells Fargo
07/24/20 B. Riley FBR
iHeartMedia price target raised to $11 from $8.50 at B. Riley FBR
04/23/20 Guggenheim
Entercom price target lowered to $3.50 from $7 at Guggenheim
ETM Entercom
$3.94 /

-0.15 (-3.67%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.